Found 41 matching trials
JAK Signaling in Depression and Cognition in Male Football Players
PHASE2This study is being done to learn more about the role of inflammation in de...
Location
Emory Clinic, Emory University Hospital
Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT)
PHASE2The MYOCIT study aims to evaluate the efficacy and safety of baricitinib in...
Location
Hôpital Pellegrin
A Study of Baricitinib (LY3009104) in Participants With COVID-19
PHASE3The reason for this study is to see if the study drug baricitinib is effect...
Location
Dignity Health Mercy Gilbert Medical Center
Safety and Efficacy of Baricitinib on Skin Tightening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With Methotrexate
PHASE3Systemic sclerosis (SSc) is a systemic autoimmune disease. It causes progre...
Efficacy and Safety of Baricitinib in Patients With Moderate and Severe COVID-19
PHASE3This is multicenter clinical trial to evaluate efficacy and safety of Baric...
Location
Dhaka Medical College, Mugda Medical College, Kuwait Bangladesh Friendship Government Hospital
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)
PHASE3The reason for this long term study is to see how safe and effective the st...
Location
Achieve Clinical Research, LLC
A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata
PHASE3The reason for this study is to see if baricitinib is safe and effective in...
Location
Total Skin and Beauty Dermatology Center, PC
A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE)
PHASE2The main purpose of this study is to evaluate the efficacy and safety of th...
Location
University of Arizona
Adaptive COVID-19 Treatment Trial 2 (ACTT-2)
PHASE3ACTT-2 will evaluate the combination of baricitinib and remdesivir compared...
Location
University of Alabama at Birmingham School of Medicine - Infectious Disease
Baricitinib for Cutaneous Dermatomyositis
PHASE2This is a phase 2, single-center study in patients with active cutaneous DM...
Location
University of Washington Medical Center